Cortisone and corticotrophin in ulcerative colitis.
作者信息
TRUELOVE S C, WITTS L J
出版信息
Br Med J. 1959 Feb 14;1(5119):387-94. doi: 10.1136/bmj.1.5119.387.
Abstract
摘要
相似文献
1
Cortisone and corticotrophin in ulcerative colitis.可的松与促肾上腺皮质激素治疗溃疡性结肠炎
Br Med J. 1959 Feb 14;1(5119):387-94. doi: 10.1136/bmj.1.5119.387.
2
The use of ACTH and cortisone in idiopathic ulcerative colitis.促肾上腺皮质激素和可的松在特发性溃疡性结肠炎中的应用。
Can Med Assoc J. 1956 Jan 1;74(1):4-9.
3
[ACTH and cortisone in treatment of nonspecific ulcerative colitis].促肾上腺皮质激素和可的松治疗非特异性溃疡性结肠炎
Prensa Med Argent. 1953 May 29;40(22):1364-71.
4
[ACTH and cortisone therapy of grave ulcerative colitis; experience in 34 cases].[促肾上腺皮质激素和可的松治疗重症溃疡性结肠炎；34例经验]
Dia Med. 1955 Nov 24;27(86):2855-64.
5
Ulcerative colitis; therapeutic effects of corticotropin (ACTH) and cortisone in 120 patients.溃疡性结肠炎；促肾上腺皮质激素（ACTH）和可的松对120例患者的治疗效果
Ann Intern Med. 1954 Aug;41(2):232-50. doi: 10.7326/0003-4819-41-2-232.
6
ACTH and cortisone therapy in ulcerative colitis.促肾上腺皮质激素和可的松疗法治疗溃疡性结肠炎。
Am J Dig Dis. 1956 May;1(5):206-14. doi: 10.1007/BF02233531.
7
Idiopathic ulcerative colitis; giant ulceration following corticotropin (ACTH) and cortisone therapy.特发性溃疡性结肠炎；促肾上腺皮质激素（ACTH）和可的松治疗后出现巨大溃疡
AMA Arch Intern Med. 1953 Jun;91(6):744-57. doi: 10.1001/archinte.1953.00240180053007.
8
[ACTH and cortisone in the medical treatment of severe ulcerative colitis].[促肾上腺皮质激素和可的松在重症溃疡性结肠炎医学治疗中的应用]
Rev Asoc Med Argent. 1954;68(777-778):349-54.
9
The use of ACTH, cortisone, hydrocortisone and related compounds in the management of ulcerative colitis; experience in 180 patients.促肾上腺皮质激素、可的松、氢化可的松及相关化合物在溃疡性结肠炎治疗中的应用；180例患者的经验
Am J Med. 1957 Feb;22(2):264-74. doi: 10.1016/0002-9343(57)90010-4.
10
ACTH and cortisone in the treatment of ulcerative colitis; an evaluation of their prolonged administration.
N Engl J Med. 1954 Jun 10;250(23):969-76. doi: 10.1056/NEJM195406102502301.
引用本文的文献
1
Post-hospitalization Short Versus Long Steroid Taper Strategies in Patients With Acute Severe Ulcerative Colitis: A Comparison of Clinical Outcomes.急性重症溃疡性结肠炎患者出院后短期与长期激素减量策略：临床结局比较
Crohns Colitis 360. 2024 Apr 27;6(2):otae025. doi: 10.1093/crocol/otae025. eCollection 2024 Apr.
2
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.口服5-氨基水杨酸用于维持溃疡性结肠炎缓解
Cochrane Database Syst Rev. 2020 Aug 28;8(8):CD000544. doi: 10.1002/14651858.CD000544.pub5.
3
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.口服5-氨基水杨酸用于诱导溃疡性结肠炎缓解
Cochrane Database Syst Rev. 2020 Aug 12;8(8):CD000543. doi: 10.1002/14651858.CD000543.pub5.
4
Cytomegalovirus infection and steroid-refractory inflammatory bowel disease: possible relationship from an updated meta-analysis.巨细胞病毒感染与类固醇难治性炎症性肠病：基于一项更新的荟萃分析的可能关系
Ir J Med Sci. 2018 Nov;187(4):935-942. doi: 10.1007/s11845-018-1752-y. Epub 2018 Feb 1.
5
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.口服5-氨基水杨酸用于维持溃疡性结肠炎的缓解。
Cochrane Database Syst Rev. 2016 May 9;2016(5):CD000544. doi: 10.1002/14651858.CD000544.pub4.
6
Budesonide for the treatment of ulcerative colitis.布地奈德用于治疗溃疡性结肠炎。
Expert Opin Pharmacother. 2016 Aug;17(11):1549-59. doi: 10.1080/14656566.2016.1183648. Epub 2016 Jun 16.
7
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.口服5-氨基水杨酸诱导溃疡性结肠炎缓解
Cochrane Database Syst Rev. 2016 Apr 21;4(4):CD000543. doi: 10.1002/14651858.CD000543.pub4.
8
The predictive variable regarding relapse in patients with ulcerative colitis after achieving endoscopic mucosal healing.溃疡性结肠炎患者实现内镜下黏膜愈合后复发的预测变量。
Intest Res. 2016 Jan;14(1):37-42. doi: 10.5217/ir.2016.14.1.37. Epub 2016 Jan 26.
9
Relationship Between Cytomegalovirus Infection and Steroid Resistance in Inflammatory Bowel Disease: A Meta-Analysis.巨细胞病毒感染与炎症性肠病中类固醇耐药性的关系：一项荟萃分析
Dig Dis Sci. 2015 Nov;60(11):3203-8. doi: 10.1007/s10620-015-3733-6. Epub 2015 Jun 2.
10
Intestinal epithelium-specific knockout of the cytochrome P450 reductase gene exacerbates dextran sulfate sodium-induced colitis.细胞色素P450还原酶基因的肠道上皮特异性敲除会加重葡聚糖硫酸钠诱导的结肠炎。
J Pharmacol Exp Ther. 2015 Jul;354(1):10-7. doi: 10.1124/jpet.115.223263. Epub 2015 Apr 29.
本文引用的文献
1
Treatment of ulcerative colitis with topical hydrocortisone hemisuccinate sodium; a controlled trial employing restricted sequential analysis.用半琥珀酸氢化可的松钠局部治疗溃疡性结肠炎；一项采用受限序贯分析的对照试验。
Br Med J. 1958 Nov 1;2(5104):1077-82. doi: 10.1136/bmj.2.5104.1077.
2
Treatment of ulcerative colitis with local hydrocortisone hemisuccinate sodium; a report on a controlled therapeutic trial.用半琥珀酸氢化可的松钠局部治疗溃疡性结肠炎；一项对照治疗试验的报告。
Br Med J. 1958 Nov 1;2(5104):1072-7. doi: 10.1136/bmj.2.5104.1072.
3
Corticosteroid therapy in chronic ulcerative colitis.
J Am Med Assoc. 1957 Apr 20;163(16):1444-8. doi: 10.1001/jama.1957.02970510010003.
4
The treatment of ulcerative colitis.
AMA Arch Intern Med. 1957 Apr;99(4):642-55. doi: 10.1001/archinte.1957.00260040142014.
5
The use of ACTH, cortisone, hydrocortisone and related compounds in the management of ulcerative colitis; experience in 180 patients.促肾上腺皮质激素、可的松、氢化可的松及相关化合物在溃疡性结肠炎治疗中的应用；180例患者的经验
Am J Med. 1957 Feb;22(2):264-74. doi: 10.1016/0002-9343(57)90010-4.
6
Problems in the management of ulcerative colitis, with particular reference to ACTH and the adrenal steroids.溃疡性结肠炎的管理问题，特别涉及促肾上腺皮质激素和肾上腺类固醇。
Ann Intern Med. 1957 Jan;46(1):1-20. doi: 10.7326/0003-4819-46-1-1.
7
The use of ACTH and cortisone in idiopathic ulcerative colitis.促肾上腺皮质激素和可的松在特发性溃疡性结肠炎中的应用。
Can Med Assoc J. 1956 Jan 1;74(1):4-9.
8
Cortisone in ulcerative colitis; final report on a therapeutic trial.可的松治疗溃疡性结肠炎；一项治疗试验的最终报告
Br Med J. 1955 Oct 29;2(4947):1041-8. doi: 10.1136/bmj.2.4947.1041.
9
Ulcerative colitis; therapeutic effects of corticotropin (ACTH) and cortisone in 120 patients.溃疡性结肠炎；促肾上腺皮质激素（ACTH）和可的松对120例患者的治疗效果
Ann Intern Med. 1954 Aug;41(2):232-50. doi: 10.7326/0003-4819-41-2-232.
Zotero 插件